Norpace CR (disopyramide phosphate) extended-release capsules USP,150 mg, packaged in a) 100-count bottles (NDC 0025-2742-31), and b) 500-count bottles (NDC 0025-2742-51), Rx only, Distributed by G.D. Searle LLC, Division of Pfizer Inc, NY, NY 10017.
Published June 26, 2013 · Recall initiated: May 31, 2013
Summary
FDA records drug Class III recall D-607-2013, published June 26, 2013 and initiated May 31, 2013. Recalling firm: Pfizer Inc; Status: Terminated; Reported quantity: 5,410 botlles; Lot: Lot #: a) C120138, Exp 07/13; b) C120137, Exp 07/13. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specification
What to do
Voluntary: Firm initiated · Letter
Get an email if NORPACE CR has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- NORPACE CR
- Manufacturer
- Pfizer Inc
- Distributor
- Nationwide and Puerto Rico
- UPC
- 0300252752314
- Lot
- Lot #: a) C120138, Exp 07/13; b) C120137, Exp 07/13
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAActiq (oral transmucosal fentanyl citrate) 200 mcg, lozenge on a stick, a)Single Blister (NDC 63459-502-01),June 26, 2013
- FDA0.9% Sodium Chloride Injection, USP, 250 mL single dose Flexible Plastic Container, Rx only, Hospira, Inc.,June 26, 2013
- FDAVECURONIUM Bromide for Injection, 10 mg* per vial, *1 mg per mL when reconstituted to 10 mL, for IV single useJune 26, 2013
- FDACleocin Phosphate (clindamycin Injection), USP, a) 600 mg/4mL (150 mg/mL) ADD-Vantage Vial, b) 900 mg/6mL (150June 26, 2013
- FDADr. Sheffield's Triple Antibiotic Ointment Bacitracin 400 units, Neomycin Sulfate 3.5mg, Polymyxin-B SulfateJune 26, 2013
- FDALightlife Farmer's Market Veggie Burgers, meat free, 12 oz/4-count bag, packaged in 5/12 oz-bag/cartons.June 26, 2013
Questions about this recall
Was Norpace CR (disopyramide phosphate) extended-release capsules USP,150 mg, packaged in a) 100-count bottles (NDC 0025-2742-31), and b) 500-count bottles (NDC 0025-2742-51), Rx only, Distributed by G.D. Searle LLC, Division of Pfizer Inc, NY, NY 10017. recalled?
Yes. FDA published recall D-607-2013 on June 26, 2013. Reported hazard: Failed Dissolution Specification
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: NORPACE CR. UPC: 0300252752314.